Ketogenesis
- Compartment
- Liver mitochondrial matrix
- Main tissue
- Liver only
- Rate-limiting
- Mitochondrial HMG-CoA synthase (HMGCS2)
- Steps
- 5
Reaction steps
In source order, 5 total
-
1
2 acetyl-CoA → acetoacetyl-CoA + CoA-SH
In Acetyl-CoA› Notes
Mitochondrial thiolase (acetyl-CoA acetyltransferase) condenses two acetyl-CoA molecules. This reaction is reversible and is shared conceptually with the terminal thiolysis step of β-oxidation.
-
2
Acetoacetyl-CoA + acetyl-CoA + H2O → 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) + CoA-SH
Mitochondrial HMG-CoA synthase (HMGCS2) 2.3.3.10 ST-0083 Irreversible/directional rate-limiting CoA-SH H2O› Notes
Mitochondrial HMG-CoA synthase (HMGCS2) catalyzes this condensation. It is the rate-limiting and committed step of ketogenesis; it is distinct from cytosolic HMG-CoA synthase used in cholesterol synthesis.
-
3
HMG-CoA → acetoacetate + acetyl-CoA
In HMG-CoA› Notes
HMG-CoA lyase cleaves HMG-CoA to the first ketone body, acetoacetate, and acetyl-CoA. No nucleotide cofactor is required.
-
4
Acetoacetate + NADH + H+ ⇌ D-β-hydroxybutyrate + NAD+
› Notes
Mitochondrial D-β-hydroxybutyrate dehydrogenase interconverts the two principal ketone bodies. The mitochondrial NADH/NAD+ ratio determines their ratio: high NADH generated by β-oxidation favors D-β-hydroxybutyrate.
-
5
Acetoacetate → acetone + CO2
In Acetoacetate› Notes
Acetoacetate undergoes slow, largely spontaneous nonenzymatic decarboxylation to acetone in humans; acetone is volatile and exhaled. This is not a productive ATP-generating step and is not a regulated enzymatic reaction.
Showing all 5 steps.
Regulation
What speeds each enzyme up and what slows it down
Mitochondrial HMG-CoA synthase (HMGCS2)
High acetyl-CoA from β-oxidation; PPARα-mediated expression; fasting
High insulin/carbohydrate availability; low fatty-acid delivery
Glucagon and low insulin induce expression indirectly through fasting transcriptional programs; insulin suppresses ketogenesis
CPT-1
Low malonyl-CoA, fatty-acyl-CoA availability
Malonyl-CoA
Glucagon/epinephrine lower malonyl-CoA and increase fatty-acid entry; insulin opposes this
Hormone-sensitive lipase/ATGL in adipose (upstream fuel supply)
Catecholamines, glucagon in humans, natriuretic peptides
Insulin; phosphodiesterase-mediated cAMP degradation
Low insulin and counterregulatory hormones increase nonesterified-fatty-acid delivery to liver
D-β-hydroxybutyrate dehydrogenase
High mitochondrial NADH/NAD+ ratio
Lower NADH/NAD+ ratio
Regulated primarily by redox state, not direct phosphorylation
Overview
Ketogenesis converts excess hepatic mitochondrial acetyl-CoA into the water-soluble ketone bodies acetoacetate and D-β-hydroxybutyrate; acetone is a minor spontaneous breakdown product. It is activated in prolonged fasting, starvation, sustained exercise, uncontrolled type 1 diabetes mellitus, and other states with high glucagon-to-insulin signaling. Ketone bodies export energy from liver to extrahepatic tissues while sparing glucose and, during prolonged fasting, reducing the need for proteolysis to supply gluconeogenic amino acids.
Cellular location
Ketogenesis occurs exclusively in the mitochondrial matrix of hepatocytes, chiefly periportal liver cells. The liver synthesizes but cannot consume ketone bodies because it lacks succinyl-CoA:3-ketoacid CoA transferase (SCOT/OXCT1). Ketone bodies cross membranes and circulate freely without lipoprotein carriers or albumin.
Net energetics
Ketogenesis itself does not produce ATP; it repackages acetyl-CoA into exportable fuel. Net formation of acetoacetate uses 2 acetyl-CoA and releases two CoA-SH; formation of D-β-hydroxybutyrate additionally consumes 1 NADH + H+ per acetoacetate reduced. The energy is recovered in extrahepatic tissues during ketolysis and subsequent oxidation of acetyl-CoA.
Clinical significance
Physiological ketosis supports brain, skeletal muscle, and heart during carbohydrate scarcity, while erythrocytes cannot use ketones because they lack mitochondria. In insulin-deficient diabetes, unchecked lipolysis and ketogenesis can produce high-anion-gap metabolic acidosis—diabetic ketoacidosis (DKA)—with dehydration, Kussmaul respirations, and fruity acetone breath. HMG-CoA lyase deficiency impairs ketone production and may cause hypoketotic hypoglycemia during fasting or illness. Nutritional ketosis is regulated and generally much less acidemic than DKA because insulin is present.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
SGLT2 inhibitors and chronic kidney disease: a narrative review of nephroprotective mechanisms from hemodynamics to metabolism.
Habas E, Rayani A, Habas A, Alarbi K, Habas A, Baghi M, Habas E, Errayes E, Hamad A, Elzouki A. · 2026-07-02
unreviewed -
2
Sulfide dynamics at the gut-microbiota interface: diet, oxygen and redox interplay.
Kumar R, Banerjee R. · 2026-06-02
open access unreviewed -
3
Gut microbiota reshapes host energy metabolism to modulate depressive behaviors.
Lei P, Qi Z, Ma Q, Zhao B, Wen B, Jiang W, Xi W, Liu Y, Xun Y, Zhang S, Wang Y, Guo Y, Wang W, Ma X, Jia M, F… · 2026-04-23
open access unreviewed -
4
Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study.
Gao M, Lin Q, Hu K, Zhong B, Zhu T, Gong Z, Zhang K, Chen X, Chen X, Zhang Y, Li Y, Tang S, Su D, Liang X, Li… · 2026-02-02
open access unreviewed -
5
Maternal obesity alters human milk oligosaccharides content and correlates with early acquisition of late colonizers in the neonatal gut microbiome.
Corona-Cervantes K, Urrutia-Baca VH, Gámez-Valdez JS, Jiménez-López B, Rodríguez-Gutierrez NA, Chávez-Caraza … · 2026-01-15
cited 2× open access unreviewed -
6
cAMP-PKA/EPAC signaling pathways: crucial regulators of lipid homeostasis.
Chen C, Gao H, Tian Q, Cao J. · 2026-01-07
open access unreviewed -
7
The ketogenic diet is not for everyone: contraindications, side effects, and drug interactions.
Dyńka D, Rodzeń Ł, Rodzeń M, Łojko D, Karakuła-Juchnowicz H, Ede G, Grzywacz Ż, Antosik K, Sethi S, Unwin D. · 2026-01-04
cited 4× open access unreviewed -
8
Vitamin D Deficiency During Pregnancy Is Associated With Greater LDL-C Increase, Elevated β-Hydroxybutyrate and Altered Neonatal Metabolic Markers-A Secondary, Pooled Analysis of the Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI).
Harreiter J, Gisinger T, Mendoza LC, Simmons D, Desoye G, Devlieger R, Galjaard S, Damm P, Mathiesen ER, Jens… · 2026-09-01
unreviewed -
9
Lipoprotein metabolism and inflammation in healthy young subjects - exploring the postprandial and postabsorptive phases following intake of a standardized meal.
Jensen SM, Holven KB, Ulven SM, Anfinsen ÅM, Dierkes J, Lysne V, Christensen JJ. · 2026-06-03
open access unreviewed -
10
SGLT2 Inhibitors in Type 1 Diabetes: The Metabolic Perspective.
Hamidi V, Mudaliar S. · 2026-08-13
unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.